CompletedNot Applicable

Digital Detection of Dementia (D Cubed) Studies: D2

United States5,325 participantsStarted 2022-07-05

Plain-language summary

The specific aim of the pragmatic trial is to evaluate the practical utility and effect of the PDM, the QDRS, and the combined approach (PDM + QDRS) in improving the annual rate of new documented ADRD diagnosis in primary care practices.

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 65 years or older * At least one visit to primary care practice within the past year * Ability to provide informed consent * Ability to communicate in English or Spanish * Available EHR data from at least the past three years Exclusion Criteria: * Prior ADRD or mild cognitive impairment diagnosis as determined by ICD-10 code * Evidence of any history of prescription for a cholinesterase inhibitors or memantine. * Has serious mental illness such as bipolar or schizophrenia as determined by ICD-10 code * Permanent resident of a nursing facility

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

12-Month Cumulative Incidence of ADRD Diagnoses

Timeframe: 12 months after index visit

Trial details

NCT IDNCT05231954

SponsorIndiana University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-07-05

Results submitted2025-07-02

View on ClinicalTrials.gov More Alzheimer Disease and Related Dementias (ADRD) trials

Who can participate

Age range

65 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.